Adtalem Global Education (NYSE:CVSA) Releases Quarterly Earnings Results, Beats Estimates By $0.19 EPS

Adtalem Global Education (NYSE:CVSA) posted its quarterly earnings results on Thursday. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.19, FiscalAI reports. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 21.05% and a net margin of 12.87%. Adtalem Global Education updated its FY 2027 guidance to 8.900-9.150 EPS.

Adtalem Global Education Price Performance

Shares of CVSA traded up $16.58 on Friday, reaching $140.84. The company’s stock had a trading volume of 686,875 shares, compared to its average volume of 355,275. The company’s 50 day moving average price is $124.68. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $4.79 billion, a PE ratio of 20.01, a P/E/G ratio of 0.94 and a beta of 0.62. Adtalem Global Education has a 12-month low of $86.97 and a 12-month high of $156.26.

Analysts Set New Price Targets

CVSA has been the subject of a number of analyst reports. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Finally, Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Insider Buying and Selling at Adtalem Global Education

In other Adtalem Global Education news, CFO Robert J. Phelan sold 2,414 shares of the stock in a transaction that occurred on Wednesday, July 8th. The shares were sold at an average price of $135.39, for a total value of $326,831.46. Following the transaction, the chief financial officer directly owned 50,492 shares in the company, valued at approximately $6,836,111.88. This trade represents a 4.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 2,439 shares of the company’s stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $135.34, for a total value of $330,094.26. Following the completion of the sale, the senior vice president owned 33,070 shares of the company’s stock, valued at $4,475,693.80. This trade represents a 6.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 15,694 shares of company stock valued at $2,098,614. Insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.